1. Derakhshan S, Khalili D, Etemad K, Hashemi Nazari S S, Kavousi A, Hadavand F, et al . Prevalence of Cardiovascular Risk Factors in Men and Women Referred to Health Centers in the Four Cities of the Ira-pen Pilot Program, 2016-2017. Iranian Journal of Endocrinology and Metabolism 2021; 23:9-20 [Persian]
2. Hadavand Siri F, Khalili D, Hashemi Nazari S S, Ostovar A, Mahdavi A. Adherence to Iran's Package of Essential Noncommunicable Diseases (IraPEN) Program for Regular Follow-up to Reduce the Risk of Cardiovascular Disease in Healthcare Centers. Iranian Journal of Endocrinology and Metabolism 2020; 22:116-126 [Persian]
3. WHO. Cardiovascular diseases. http//www.emro.who.int/healthtopics/ cardiovascular-diseases/index.html. [Access date:16/04/2022]
4. Harirchi I MS, Ahmadnezhad E, Abdi Z. Observatory on Health System. Islamic Republic of Iran, National Institute for Health Research Tehran: Aftab-e-Andishe. 2017. https://nih.tums.ac.ir/Show/Item/660
5. Sadeghi V JA, Sadeghi-Bazargani H, Imani A. Which Interventions should be Included in National Health System Assessment Framework? Selecting Essential Interventions Based on Effective Coverage Approach. Annals of Medical and Health Science Research 2019;9:542-9
6. Koosha A NM ea. Package of Essential Non-Communicable (PEN) Disease Interventions for Primary Health Care in Iran (IraPEN). (Implementation Tools for General Practitioner). Tehran: Ministry of Health and Medical Education: IranTehran:Mojassameh; 2017. https://malard.iums.ac.ir/files/malard/files/%D9%81%D8%B4%D8%A7%D8%B1_%D8%AE%D9%88%D9%6/%D8%A7%DB%8C%D8%B1%D8%A7%D9%BE%D9%86/FixMohtava-Behvarz.pdf
7. Jahani MA BM, Abbasi M, Yazdani Charati J, Mahmoodi G. Analysis of the Results of Cardiovascular Disease Risk Assessment Program. Journal of Babol University of Medical Sciences 2021;23:236-43 [Persian]
8. Motamed N ea. The 10-year absolute risk of cardiovascular (CV) events in northern Iran: A Population Based Study. Materia Socio-Medica 2015; 27:158-62 [
DOI:10.5455/msm.2015.27.158-162]
9. Karami M, Mobasheri F, Khosravi Shadmani F. Potential Impact Fraction of modifying selected risk factors on burden of cardiovascular disease in Iran: comparative risk assessment. Razi Journal of Medical Sciences 2013;20:62-71 [Persian]
10. Bansal M, Kasliwal RR. Optimum cardiovascular risk prediction algorithm for South-Asians - Are WHO risk prediction charts really the right answer? Indian Heart Journal 2016;68:581-2 [
DOI:10.1016/j.ihj.2016.05.007]
11. Van der Aalst CM, Denissen S, Vonder M, Gratama JWC, Adriaansen HJ, Kuijpers D, et al. screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial. Journal of the European Society of Cardiology 2020;21:1216-24 [
DOI:10.1093/ehjci/jeaa168]
12. Nakhaie MR, Koor BE, Salehi SO, Karimpour F. Prediction of cardiovascular disease risk using Framingham risk score among office workers, Iran, 2017. Saudi Journal of Kidney Diseases and Transplantation 2018;29:608-14 [
DOI:10.4103/1319-2442.235179]
13. Hajian-Tilaki K, Heidari B. Comparison of abdominal obesity measures in predicting of 10-year cardiovascular risk in an Iranian adult population using ACC/AHA risk model: A population based cross sectional study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2018;12:991-7 [
DOI:10.1016/j.dsx.2018.06.012]
14. Hojat M, Jahromi M, Koshkaki S, Rahmanian M. Comparison of risk factors of cardiovascular diseases in male and female nurses. Journal of Education and Health Promotion 2019;8:19-19
15. Bowry AD, Lewey J, Dugani SB, Choudhry NK. The Burden of Cardiovascular Disease in Low- and Middle-Income Countries: Epidemiology and Management. Canadian Journal of Cardiology 2015;31:1151-9 [
DOI:10.1016/j.cjca.2015.06.028]
16. Sarrafzadegan N, Mohammmadifard N. Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention. Archives of Iranian Medicine 2019;22:204-10